Edgewell Personal Care Company (EPC) Balance Sheet

The balance sheet has shown remarkable stability in absolute terms, with total assets hovering around $3.5-3.8B over the last ten quarters. However, equity has declined from $1.6B in 2025Q4 to $1.5B in 2026Q3, a 6% drop, driven by net losses and share repurchases. This suggests that while the company is not aggressively levering up, it is also not building equity through retained earnings, which may indicate a period of stagnant profitability.

Total debt has remained elevated at around $1.3-1.6B, with D/E fluctuating between 0.83 and 1.05. The recent uptick to 0.88 in 2026Q3, despite a slight reduction in absolute debt, reflects the contraction in equity. This leverage level is moderate for a consumer staples company, but the thin net margin of 1.14% leaves little room for error if interest rates rise or cash flows weaken. The company's ability to service this debt appears adequate given stable operating cash flows, but investors should monitor the interest coverage ratio.

The asset mix is heavily weighted toward goodwill and intangibles, which at $1.1B constitute a significant portion of the balance sheet. This is typical for a company that has grown through acquisitions, but it also exposes the balance sheet to potential impairment charges if the acquired brands underperform. The decline in PPE from $434.5M to $292.7M over the same period suggests either asset sales or increased depreciation, which may indicate a rationalization of manufacturing capacity. The high goodwill balance warrants close monitoring, especially given the recent revenue stagnation.

Equity has declined from $1.6B in 2025Q4 to $1.5B in 2026Q3, a 6% drop, driven by a net loss in 2026Q1 and continued share repurchases. Retained earnings have been stagnant at $1.0B, indicating that the company is not generating sufficient profits to build equity. The combination of thin margins and buybacks suggests that management is returning cash to shareholders despite weak earnings, which may be a signal of limited organic growth opportunities.

The company has significantly bolstered its cash position, nearly doubling from $199.6M to $397.1M over the past year. This has improved the current ratio to 1.84, which is above the 1.5 threshold typically considered healthy. The cash build may be a deliberate strategy to fund M&A or to provide a cushion against seasonal working capital swings. However, the high debt load of $1.3B means that net debt remains substantial, and the liquidity position should be viewed in that context.